Idexx Laboratories (IDXX) Stock
Idexx Laboratories (IDXX) closed at $704.23 on Nov 13, 2026; its Tenet Score is 51 of 100 against 313 Healthcare peers.
6 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $704.23
- Nov 13, 2026
- Market cap
- $55.5B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 47.1×
- price ÷ earnings
- 52-week range
- 500.61 – 769.98
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 51/100
- Mixed · 313 Healthcare peers
Industry: Drugs
Idexx Laboratories, Inc. scores 51/100. Mixed. Strongest on quality and growth, value is the soft spot, trading at 47× earnings versus 313 Healthcare peers.
Tenet Score · vs sector
n=313Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ✓ Piotroski F-Score
- ✓ Munger Compounders
- ~ Magic Formula
- ✕ Graham Defensive
- ✕ Lynch GARP
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Regeneron Pharmaceuticals, Inc.REGN | 64 | $98.8B |
| Moderna IncMRNA | 33 | $90.4B |
| Takeda Pharmaceutical CoTAK | 32 | $73.9B |
| Argen X SEARGX | 71 | $59.4B |
| Teva- Pharmaceutical Industries Ltd.TEVA | 34 | $51.9B |
| BeOne Medicines LtdONC | 64 | $47.6B |
| Biogen IncBIIB | 39 | $37.5B |
| Revolution Medicines IncRVMD | 40 | $37.3B |
| Zoetis IncZTS | 59 | $34.1B |
| Illumina IncILMN | 52 | $31.3B |
Compare Idexx Laboratories with
Common questions
What sector and industry is Idexx Laboratories in?
Idexx Laboratories is in the Healthcare sector and the Drugs industry.
What is Idexx Laboratories' Tenet Score?
Idexx Laboratories' Tenet Score is 51 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




